KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

VivoSim Labs (VIVS) Shares Outstanding (Weighted Average) (2016 - 2025)

VivoSim Labs (VIVS) has 15 years of Shares Outstanding (Weighted Average) data on record, last reported at $2.6 million in Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 73.32% year-over-year to $2.6 million; the TTM value through Dec 2025 reached $2.6 million, up 73.32%, while the annual FY2025 figure was $1.5 million, 92.06% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $2.6 million in Q4 2025 per VIVS's latest filing, up from $2.6 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $9.1 million in Q4 2023 and bottomed at $762076.0 in Q1 2024.
  • Average Shares Outstanding (Weighted Average) over 5 years is $5.9 million, with a median of $8.7 million recorded in 2021.
  • Peak YoY movement for Shares Outstanding (Weighted Average): crashed 91.25% in 2024, then soared 104.89% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $8.7 million in 2021, then increased by 0.12% to $8.7 million in 2022, then grew by 4.61% to $9.1 million in 2023, then plummeted by 83.49% to $1.5 million in 2024, then soared by 73.32% to $2.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Weighted Average) were $2.6 million in Q4 2025, $2.6 million in Q3 2025, and $2.5 million in Q2 2025.